{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:45:27Z","timestamp":1777610727704,"version":"3.51.4"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T00:00:00Z","timestamp":1694563200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010044","name":"University of Central Lancashire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010044","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jim.2023.113556","type":"journal-article","created":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T11:09:47Z","timestamp":1693998587000},"page":"113556","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Optimisation of SARS-CoV-2 peptide stimulation and measurement of cytokine output by intracellular flow cytometry and bio-plex analysis"],"prefix":"10.1016","volume":"522","author":[{"given":"Jemma Victoria","family":"Taylor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma Louise","family":"Callery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Rowbottom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jim.2023.113556_bb0005","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s40620-021-01092-0","article-title":"Detection of pre-existing SARS-CoV-2-reactive T cells in unexposed renal transplant patients","volume":"34","author":"Anft","year":"2021","journal-title":"J. Nephrol."},{"issue":"5","key":"10.1016\/j.jim.2023.113556_bb0010","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.autrev.2011.05.001","article-title":"Therapeutic blockade of TNF in patients with SLE\u2014promising or crazy?","volume":"11","author":"Aringer","year":"2012","journal-title":"Autoimmun. Rev."},{"issue":"10","key":"10.1016\/j.jim.2023.113556_bb0015","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1002\/art.20576","article-title":"Safety and efficacy of tumor necrosis factor\u00a0? Blockade in systemic lupus erythematosus: an open-label study","volume":"50","author":"Aringer","year":"2004","journal-title":"Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.jim.2023.113556_bb0020","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1111\/all.14364","article-title":"Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19","volume":"75","author":"Azkur","year":"2020","journal-title":"Allergy."},{"issue":"6515","key":"10.1016\/j.jim.2023.113556_bb0025","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I ifns in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science."},{"issue":"6","key":"10.1016\/j.jim.2023.113556_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109504","article-title":"Systemic IL-15, IFN-\u03b3, and IP-10\/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients","volume":"36","author":"Bergamaschi","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.jim.2023.113556_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.890517","article-title":"COVID-19 and preexisting comorbidities: risks, synergies, and clinical outcomes","volume":"13","author":"Bigdelou","year":"2022","journal-title":"Front. Immunol."},{"issue":"18","key":"10.1016\/j.jim.2023.113556_bb0040","first-page":"9695","article-title":"The first case of systemic lupus erythematosus (SLE) triggered by COVID-19 infection","volume":"24","author":"Bonometti","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"5","key":"10.1016\/j.jim.2023.113556_bb0045","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunological features of severe and moderate coronavirus disease 2019","volume":"130","author":"Chen","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.jim.2023.113556_bb0050","article-title":"Measurement of cell death in mammalian cells","volume":"0","author":"Cummings","year":"2004","journal-title":"Curr. Protoc. Pharmacol."},{"key":"10.1016\/j.jim.2023.113556_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101019","article-title":"Characterizing long COVID in an international cohort: 7 months of symptoms and their impact","volume":"38","author":"Davis","year":"2021","journal-title":"eClinicalMedicine"},{"issue":"12","key":"10.1016\/j.jim.2023.113556_bb0060","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1217","article-title":"Severe SARS-CoV-2 patients develop a higher specific T-cell response","volume":"9","author":"Demaret","year":"2020","journal-title":"Clin. Transl. Immunol."},{"issue":"9","key":"10.1016\/j.jim.2023.113556_bb0065","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S1473-3099(20)30262-0","article-title":"Baricitinib for COVID-19: a suitable treatment?","volume":"20","author":"Favalli","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jim.2023.113556_bb0070","first-page":"9","article-title":"Case report: secondary Hemophagocytic Lymphohistiocytosis (sHLH) and Candida auris Fungemia in post-acute COVID-19 syndrome: a clinical challenge","author":"Gautam","year":"2022","journal-title":"Front. Med."},{"issue":"59","key":"10.1016\/j.jim.2023.113556_bb0075","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abj1750","article-title":"SARS-CoV-2 variants of concern partially escape humoral but not T cell responses in COVID-19 convalescent donors and vaccine recipients","volume":"6","author":"Geers","year":"2021","journal-title":"Sci. Immunol."},{"issue":"6","key":"10.1016\/j.jim.2023.113556_bb0080","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.chom.2020.04.009","article-title":"Complex immune dysregulation in COVID-19 patients with severe respiratory failure","volume":"27","author":"Giamarellos-Bourboulis","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"4","key":"10.1016\/j.jim.2023.113556_bb0085","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00296-021-04794-7","article-title":"Can the SARS-CoV-2 infection trigger systemic lupus erythematosus? A case-based review","volume":"41","author":"Gracia-Ramos","year":"2021","journal-title":"Rheumatol. Int."},{"issue":"7","key":"10.1016\/j.jim.2023.113556_bb0090","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell."},{"key":"10.1016\/j.jim.2023.113556_bb0095","first-page":"11","article-title":"The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak \u2013 an update on the status","volume":"7","author":"Guo","year":"2020","journal-title":"Mil. Med. Res."},{"issue":"4","key":"10.1016\/j.jim.2023.113556_bb0100","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1182\/blood.2019000952","article-title":"Cytokines and costimulation in acute graft-versus-host disease","volume":"136","author":"Hill","year":"2020","journal-title":"Blood."},{"issue":"2","key":"10.1016\/j.jim.2023.113556_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell."},{"issue":"1","key":"10.1016\/j.jim.2023.113556_bb0110","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s41232-020-00146-3","article-title":"How COVID-19 induces cytokine storm with high mortality","volume":"40","author":"Hojyo","year":"2020","journal-title":"Inflamm. Regen."},{"issue":"2","key":"10.1016\/j.jim.2023.113556_bb0115","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/jmv.20255","article-title":"An interferon-\u03b3-related cytokine storm in SARS patients","volume":"75","author":"Huang","year":"2005","journal-title":"J. Med. Virol."},{"issue":"10223","key":"10.1016\/j.jim.2023.113556_bb0120","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jim.2023.113556_bb0125","article-title":"A case report of multiple sclerosis after COVID-19 infection: causality or coincidence?","volume":"1","author":"Ismail","year":"2021","journal-title":"Neuroimmunol. Rep."},{"key":"10.1016\/j.jim.2023.113556_bb0130","author":"John Hopkins University of Medicine"},{"issue":"4","key":"10.1016\/j.jim.2023.113556_bb0135","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/TP.0000000000004057","article-title":"Higher Proinflammatory cytokines are associated with increased antibody titer after a third dose of SARS-CoV-2 vaccine in solid organ transplant recipients","volume":"106","author":"Karaba","year":"2022","journal-title":"Transplantation."},{"key":"10.1016\/j.jim.2023.113556_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.110031","article-title":"Are graphene and graphene-derived products capable of preventing COVID-19 infection?","volume":"144","author":"Kumar Raghav","year":"2020","journal-title":"Med. Hypotheses"},{"issue":"7821","key":"10.1016\/j.jim.2023.113556_bb0145","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41586-020-2550-z","article-title":"SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls","volume":"584","author":"Le Bert","year":"2020","journal-title":"Nature."},{"issue":"5","key":"10.1016\/j.jim.2023.113556_bb0150","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/bcpt.12107","article-title":"Brefeldin a induces apoptosis by activating the mitochondrial and death receptor pathways and inhibits focal adhesion kinase-mediated cell invasion","volume":"113","author":"Lee","year":"2013","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"4","key":"10.1016\/j.jim.2023.113556_bb0155","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/jmv.25678","article-title":"Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle","volume":"92","author":"Lu","year":"2020","journal-title":"J. Med. Virol."},{"issue":"10224","key":"10.1016\/j.jim.2023.113556_bb0160","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet."},{"issue":"1","key":"10.1016\/j.jim.2023.113556_bb0165","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0022-1759(01)00416-1","article-title":"Use of overlapping peptide mixtures as antigens for cytokine flow cytometry","volume":"255","author":"Maecker","year":"2001","journal-title":"J. Immunol. Methods"},{"issue":"5","key":"10.1016\/j.jim.2023.113556_bb0170","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1395","article-title":"G-CSF induces CD15+ CD14+ cells from granulocytes early in the physiological environment of pregnancy and the cancer immunosuppressive microenvironment","volume":"11","author":"Maneta","year":"2022","journal-title":"Clin. Transl. Immunol."},{"issue":"9","key":"10.1016\/j.jim.2023.113556_bb0175","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1007\/s10067-020-05310-1","article-title":"Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiology","volume":"39","author":"Mantovani Cardoso","year":"2020","journal-title":"Clin. Rheumatol."},{"issue":"16","key":"10.1016\/j.jim.2023.113556_bb0180","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric antigen receptor T cells for sustained remissions in leukemia","volume":"371","author":"Maude","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jim.2023.113556_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104859","article-title":"Candidate drugs against SARS-CoV-2 and COVID-19","volume":"157","author":"McKee","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.jim.2023.113556_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.04.004","article-title":"Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2","volume":"181","author":"Monteil","year":"2020","journal-title":"Cell."},{"key":"10.1016\/j.jim.2023.113556_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ensci.2020.100299","article-title":"A first presentation of multiple sclerosis with concurrent COVID-19 infection","volume":"22","author":"Moore","year":"2021","journal-title":"eNeurologicalSci."},{"issue":"4","key":"10.1016\/j.jim.2023.113556_bb0200","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.micinf.2020.04.009","article-title":"Bioinformatic analysis and identification of single-stranded RNA sequences recognized by TLR7\/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes","volume":"22","author":"Moreno-Eutimio","year":"2020","journal-title":"Microbes Infect."},{"issue":"17","key":"10.1016\/j.jim.2023.113556_bb0205","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.vaccine.2016.02.063","article-title":"Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection","volume":"34","author":"Ng","year":"2016","journal-title":"Vaccine."},{"key":"10.1016\/j.jim.2023.113556_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102377","article-title":"Multiple sclerosis following SARS-CoV-2 infection","volume":"45","author":"Palao","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"11","key":"10.1016\/j.jim.2023.113556_bb0215","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/s41590-020-0782-6","article-title":"Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19","volume":"21","author":"Peng","year":"2020","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.jim.2023.113556_bb0220","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41590-021-01113-x","article-title":"Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection","volume":"23","author":"Phetsouphanh","year":"2022","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.jim.2023.113556_bb0225","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211387","article-title":"Human autoantibodies underlying infectious diseases","volume":"219","author":"Puel","year":"2022","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.jim.2023.113556_bb0230","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1038\/s41598-022-20773-9","article-title":"Experimental and clinical data analysis for identification of COVID-19 resistant ACE2 mutations","volume":"13","author":"Raghav","year":"2023","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.jim.2023.113556_bb0235","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cell.2020.11.029","article-title":"Functional SARS-CoV-2-specific immune memory persists after mild COVID-19","volume":"184","author":"Rodda","year":"2021","journal-title":"Cell."},{"issue":"1","key":"10.1016\/j.jim.2023.113556_bb0240","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cell.2020.08.017","article-title":"Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19","volume":"183","author":"Sekine","year":"2020","journal-title":"Cell."},{"issue":"1","key":"10.1016\/j.jim.2023.113556_bb0245","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1365-2141.2008.07298.x","article-title":"Early diagnostic and prognostic significance of a specific Th1\/Th2 cytokine pattern in children with haemophagocytic syndrome","volume":"143","author":"Tang","year":"2008","journal-title":"Br. J. Haematol."},{"issue":"6","key":"10.1016\/j.jim.2023.113556_bb0250","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: immunity, inflammation and intervention","volume":"20","author":"Tay","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.jim.2023.113556_bb0255","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nrrheum.2009.181","article-title":"Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis","volume":"5","author":"Taylor","year":"2009","journal-title":"Nat. Rev. Rheumatol."},{"issue":"6","key":"10.1016\/j.jim.2023.113556_bb0260","article-title":"Robust T cell response toward spike, membrane, and Nucleocapsid SARS-CoV-2 proteins is not associated with recovery in critical COVID-19 patients","volume":"1","author":"Thieme","year":"2020","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.jim.2023.113556_bb0265","first-page":"11","article-title":"Tempering macrophage plasticity for controlling SARS-CoV-2 infection for managing COVID-19 disease","author":"Toor","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.jim.2023.113556_bb0270","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s11739-020-02345-9","article-title":"Camostat mesilate therapy for COVID-19","volume":"15","author":"Uno","year":"2020","journal-title":"Intern. Emerg. Med."},{"issue":"8","key":"10.1016\/j.jim.2023.113556_bb0275","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1177\/0961203309102557","article-title":"Efficacy and safety of infliximab in active SLE: a pilot study","volume":"18","author":"Uppal","year":"2009","journal-title":"Lupus."},{"issue":"9","key":"10.1016\/j.jim.2023.113556_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007142","article-title":"Inducible bronchus-associated lymphoid tissue elicited by a protein cage nanoparticle enhances protection in mice against diverse respiratory viruses","volume":"4","author":"Wiley","year":"2009","journal-title":"PLoS One"},{"issue":"21","key":"10.1016\/j.jim.2023.113556_bb0285","doi-asserted-by":"crossref","first-page":"11385","DOI":"10.1128\/JVI.01363-09","article-title":"Rhesus Theta-Defensin prevents death in a mouse model of severe acute respiratory syndrome coronavirus pulmonary disease","volume":"83","author":"Wohlford-Lenane","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.jim.2023.113556_bb0290","author":"World Health Organization"},{"issue":"4","key":"10.1016\/j.jim.2023.113556_bb0295","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"14","key":"10.1016\/j.jim.2023.113556_bb0300","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aan5393","article-title":"Recovery from the Middle East respiratory syndrome is associated with antibody and T cell responses","volume":"2","author":"Zhao","year":"2017","journal-title":"Sci. Immunol."}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175923001382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175923001382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T16:36:10Z","timestamp":1758299770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175923001382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":60,"alternative-id":["S0022175923001382"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2023.113556","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimisation of SARS-CoV-2 peptide stimulation and measurement of cytokine output by intracellular flow cytometry and bio-plex analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2023.113556","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113556"}}